Director of Biopharmaceutics, Executive Vice PresidentTiumbio Co.,LtdSeongnam-si, Kyonggi-do, Republic of Korea
PB0509 - Phase 1a Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Single Ascending Doses of Intravenous TU7710 in Warfarin Pretreated Healthy Male Subjects
Monday, June 24, 202413:45 – 14:45 ICT